4D Molecular Therapeutics CEO David Kirn's 2023 pay jumps 213% to $10M
4D Molecular Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 10, 2024
4D Molecular Therapeutics reported fiscal year 2023 executive compensation information on April 10, 2024.
In 2023, three executives at 4D Molecular Therapeutics received on average a compensation package of $6.3M, a 139% increase compared to previous year.
Average pay of disclosed executives at 4D Molecular Therapeutics
David Kirn, Chief Executive Officer, received $10M in total, which increased by 213% compared to 2022. 90% of Kirn's compensation, or $9.3M, was in option awards. Kirn also received $395K in non-equity incentive plan, $597K in salary, as well as $17K in other compensation.
Fariborz Kamal, Chief Operating Officer, received a compensation package of $4.5M, which increased by 90% compared to previous year. 83% of the compensation package, or $3.8M, was in option awards.
Robert Kim, Chief Medical Officer, earned $4M in 2023.
Related executives
You may also like
Source: SEC filing on April 10, 2024.